Nathan Grant Adams
Physician in Salt Lake City, UT

License number

Utah 7961990-1205

Issued Date

Jan 26, 2012

Expiration Date

Jan 31, 2018

Personal information

See more information about Nathan Grant Adams at radaris.com

Name

Address

Phone

Nathan Adams, age 44

4769 W Arno Way, West Jordan, UT 84084

(801) 967-9049

Nathan Adams, age 40

455 N 900 E, Lehi, UT 84043

Nathan Adams, age 43

35 W 200 N, Washington, UT 84780

Nathan Adams, age 55

909 N 4000 W, Clearfield, UT 84015

Nathan I Adams, age 52

951 Main St, American Fork, UT 84003

Professional information

Dr. Nathan G Adams, Mankato MN - MD (Doctor of Medicine)

Specialties:

General Surgery

Age:

Address:

ASSOCIATES IN ORAL MAX FACIAL SURGERY
1990 Premier Dr, Mankato 56001
(507) 625-9330 (Phone), (507) 625-1440 (Fax)
KARL E LIND DDS A PROFESSIONAL CORPORATION
3920 S 1100 E SUITE 150, Salt Lake City 84124
(801) 262-7447 (Phone), (801) 262-7447 (Fax)

Procedures:

Incisional/Ventral Hernia Repair, Open

Conditions:

Incisional Hernia

Languages:

English

Education:

Medical School
Mayo Medical School
Graduated: 2010

Accountant At Flying J

Position:

accountant at flying j

Location:

Greater Salt Lake City Area

Industry:

Accounting

Work:

flying j - accountant

Estrenes For Inducting Hypothalamic Effects

US Patent:

6352980, Mar 5, 2002

Filed:

Sep 21, 1999

Appl. No.:

09/399977

Inventors:

David L. Berliner - Atherton CA
Nathan W. Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT

Assignee:

Pherin Pharmaceuticals, Inc. - Mountain View CA

International Classification:

A61K 3156

US Classification:

514169, 514170, 514177, 514178, 514182

Abstract:

The invention relates to estrene steroids, which bind to neuroepithelial receptors. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

Nathan G Adams, Salt Lake City UT

Specialties:

Oral Surgeon

Address:

3920 S 1100 E, Salt Lake City, UT 84124

Pregnane Steroids As Neurochemical Initiators Of Change In Human Hypothalamic Function And Related Pharmaceutical Compositions And Methods

US Patent:

5563131, Oct 8, 1996

Filed:

Aug 4, 1994

Appl. No.:

8/286073

Inventors:

David L. Berliner - Atherton CA
Clive L. Jennings-White - Salt Lake City UT
Nathan W. Adams - Salt Lake City UT

Assignee:

Pherin Corporation - Menlo Park CA

International Classification:

A61K 3156

US Classification:

514177

Abstract:

The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e. g. a pregnane steroid, or a pharmaceutical composition containing a vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.

Androstane Steroids As Neurochemical Initiators Of Change In Human Hypothalamic Function And Related Pharmaceutical Compositions And Methods

US Patent:

2002014, Oct 3, 2002

Filed:

Aug 3, 2001

Appl. No.:

09/922216

Inventors:

David Berliner - Atherton CA, US
Nathan Adams - Salt Lake City UT, US
Clive Jennings-White - Salt Lake City UT, US

International Classification:

A61K031/56

US Classification:

514/182000, 514/179000

Abstract:

The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Androstane steroid, or a pharmaceutical composition containing a semiochemical, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.

Method Of Altering Hypothalamic Function By Nasal Administration Of Estrene Steroids

US Patent:

5783571, Jul 21, 1998

Filed:

Sep 28, 1993

Appl. No.:

8/127980

Inventors:

David L. Berliner - Atherton CA
Nathan William Adams - Salt Lake City UT
Clive L. Jennings-White - Salt Lake City UT

Assignee:

Pherin Corporation - Menlo Park CA

International Classification:

A61K 3156

US Classification:

514177

Abstract:

The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e. g. an Estrene steroid, or a pharmaceutical composition containing an Estrene steroid, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.

Steroids As Neurochemical Initiators Of Change In Human Blood Levels Of Lh

US Patent:

6066627, May 23, 2000

Filed:

Mar 29, 1996

Appl. No.:

8/625268

Inventors:

Clive L. Jennings-White - Salt Lake City UT
David L. Berliner - Atherton CA
Nathan W. Adams - Salt Lake City UT

Assignee:

Pherin Corporation - Menlo Park CA

International Classification:

A61K 3156

US Classification:

514177

Abstract:

The invention relates to a method of altering the blood levels of LH or FSH in an individual. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.